“…Chronic hepatitis C (CHC), because of concomitant insulin resistance (IR) [6,7], high prevalence of steatosis [8,9], increased prevalence of impaired glucose tolerance and/or type 2 diabetes mellitus (T2DM) [10,11,12] and changes in lipid metabolism [13], has been considered not only as a viral disease, but also as a metabolic liver disease. Moreover, IR is a strong predictor of poor response to antiviral therapy, alongside advanced hepatic steatosis and fibrosis [6,14].…”